Antibiotics Market Share

Report ID: GMI8014
Published Date: Feb 2024
Report Format: PDF

Download Free Sample

Antibiotics Market Share

The competitive landscape of the market is characterized by the presence of established pharmaceutical companies vying for market share. Key players are engaging in strategic initiatives such as mergers, acquisitions, and partnerships to strengthen their product portfolios. The companies are actively adopting a multi-pronged approaches to address the rising demand for effective antibiotics.

Antibiotics Market Companies

Prominent players operating in the antibiotics industry are as mentioned below:

Abbott Laboratories
AbbVie, Inc.
Allergan plc
Basilea Pharmaceutica Ltd.
Bayer AG
Bristol Myers Squibb
Cipla Inc.
Daiichi Sankyo Company Ltd.
Eli Lilly & Co.
GlaxoSmithKline plc.
Johnson & Johnson
Lupin Inc.
Melinta Therapeutics LLC
Merck & Co.
Novartis AG
Pfizer Inc.
Sandoz
Sanofi
Teva Pharmaceutical Industries Ltd.
Viatris Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global antibiotics industry was valued at USD 45.6 billion in 2023 and is expected to reach USD 60.9 billion by 2032 growing at a CAGR of 3.3% over the analysis period driven by the growing aging population and the continual development of novel antibiotic formulations.

The UTI application is expected to lead the market, projecting the revenue of USD 23.3 billion by 2032, owing to the high incidence of UTIs, particularly among women, that propels the need for antibiotics such as ciprofloxacin and trimethoprim-sulfamethoxazole, crucial in managing these infections.

North America antibiotics market is expected to record strong CAGR throughout 2024 and 2032 due to the high incidence of infectious diseases such as pneumonia and TB.

Abbott Laboratories, AbbVie, Inc., Allergan plc, Basilea Pharmaceutica Ltd., Bayer AG, Bristol Myers Squibb, Cipla Inc., Daiichi Sankyo Company Ltd., Eli Lilly & Co., GlaxoSmithKline plc., Johnson & Johnson, Lupin Inc., Melinta Therapeutics LLC, Merck & Co., Novartis AG, Pfizer Inc., Sandoz, Sanofi, Teva Pharmaceutical Industries Ltd., and Viatris Inc.